Study of Glycopyrronium in Axillary Hyperhydrosis

PHASE3CompletedINTERVENTIONAL
Enrollment

344

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Hyperhidrosis
Interventions
DRUG

glycopyrronium Topical Wipes

Topical wipes containing glycopyrronium

OTHER

Vehicle

Vehicle (placebo) topical wipes

Trial Locations (31)

10117

Klinik fur Dermatologie, Allergologie und Venerologie Allergie-Centrum-Charite, Berlin

15831

Dermatolosche Gemeinschaftspraxis, Mahlow

22911

Charlottesville Dermatology Research Center, Charlottesville

23507

Virginia Clinical Research, Inc., Norfolk

24148

Tagesklinik DermaKiel, Kiel

25348

Hautarztpraxis, Glückstadt

25421

Hautarztpraxis, Pinneberg

29414

Dermatology and Laser Center, Charleston

33144

International Dermatology Research, Inc., Miami

33162

Tory Sullivan, M.D., P.A., North Miami Beach

33401

Research Institute of the Southeast, West Palm Beach

33437

Study Protocol, Inc., Boynton Beach

33486

Skin Care Research, Inc., Boca Raton

36608

Coastal Clinical Research, Inc., Mobile

37072

Rivergate Dermatology Clinical Research Center, PLLC, Goodlettsville

46168

The Indiana Clinical Trials Center, Plainfield

48249

Pro DERMA im Hautzentrum Dulmen, Dülmen

63122

St. Louis University Dermatology, St Louis

67226

Prairie Health and Wellness, Wichita

68134

Meridian Clinical Research, Omaha

70499

Hautarztpraxis, Stuttgart

75024

ACRC Trials / Innovative Dermatology, Plano

77845

J&S Studies, College Station

78218

Texas Dermatology and Laser Specialists, San Antonio

78759

DermResearch, Austin

78860

Austin Institute for Clinical Research, Pflugerville

88045

Medical Practice and Derma Study Center Friedrichshafen GmbH, Friedrichshafen

92024

California Dermatology & Clinical Research Institute, Encinitas

92123

Therapeutics Clinical Research, San Diego

97421

Gemeinschaftspraxis Weber & Cranic, Schweinfurt

07548

SRH Wald-Klinikum Gera GmbH, Gera

Sponsors
All Listed Sponsors
lead

Journey Medical Corporation

INDUSTRY

NCT02530281 - Study of Glycopyrronium in Axillary Hyperhydrosis | Biotech Hunter | Biotech Hunter